Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
302
Patients in the smartwatch group will undergo rhythm monitoring with a smartwatch
Detected POAF episodes will be confirmed via a 12-lead ECG
Centre hospitalier Amiens
Amiens, France
RECRUITINGthe incidence of POAF
the incidence of POAF within seven days after scheduled thoracic surgery.
Time frame: at day 7
Rate of asymptomatic POAF
Rate of asymptomatic POAF, evaluated using the EHRA symptom score
Time frame: at day 7
Cardiovascular prognosis
Cardiovascular prognosis assessed through a composite outcome (MACE)
Time frame: at day 3
Cardiovascular prognosis
Cardiovascular prognosis assessed through a composite outcome (MACE)
Time frame: at 6 months
Feasibility of rhythm monitoring with a smartwatch
Feasibility of rhythm monitoring with a smartwatch, measured by device usage time and the proportion of successful single-lead ECGs performed.
Time frame: at day 7
Recurrence of AF
Recurrence of AF
Time frame: at 3 months
Recurrence of AF
Recurrence of AF
Time frame: at 6 months
management of AF
management of AF
Time frame: at 3 months
management of AF
management of AF
Time frame: at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.